Bernard Lapointe has extensive experience in the resource sector. He holds a B.A. in geology from the University of Québec (Montreal; 1980), a Masters degree in structural geology from the University of Québec (Chicoutimi), and a Ph.D. in mineral resources from the University of Québec (Chicoutimi).
He founded Arianne Resources (now named Arianne Phosphate TSX-V: DAN) in
1997 and acted as CEO until 2013. Arianne Phosphate is developing the biggest
Greenfield igneous phosphate project in the world. Prior to Arianne, he served as director of the Saguenay-Lac- St-Jean Mining Fund and also acted as a geochemist analyst for the University of Québec at Chicoutimi.
Bernard is now a semi-retired geologist, consultant and a private investor. He is lecturer at the University of Québec at Chicoutimi in Exploration Financing. He recently attended in Germany a short course on Geothermal Reservoir Engineering.
Peter P. Swistak, President/CEO of Cavan Ventures Inc., states, " The depth and scope of Mr.Lapointe is unparalleled and Cavan is very fortunate to have access to this knowledge as we
believe he is the best in his field with an extensive bio and proven track record. He will add tremendous value, credibility and unique knowledge to Cavan .
Director of Research & Development
Mr. Matthew Harvey is the Founder and Chief Executive Officer of BC Bud Depot (“BCBD”), a producer of marijuana seeds. Mr. Harvey has been Director of Research & Development at Cavan Ventures Inc. since October 2014.
He has been a master grower and in the industry since the mid-1990’s with world-wide exposure since 2004. During his tenure at BCBD, a cannabis seed producer and creator of award-winning THC and CBD strains, BCBD has received over 23 Cannabis Cup awards, including nine international First Place awards. BCBD was in 2009 inducted into the Seed Bank Hall of Fame.
Additionally, BC Bud Depot has outreach to over 11 North American dispensaries and over 60 worldwide retail and web stores which stock BCBD’S products. He has steered BCBD towards a new developmental approach to medicinal genetics, producing unique strains to be used for specific medical ailments. He has been a Member of Advisory Board at Cavan Ventures Inc. since May 2014.
Subscribe now and receive weekly newsletter from us!